E-LIB Suche - Ergebnisse für: Pink, John

1

Impact of age, antiretroviral therapy, and cancer on epigen..:

Qing, Yulan ; Chan, Ricky ; Fu, Pingfu...
Cancer Medicine. 12 (2023) 9 - p. 11010-11019 , 2023

Link: https://doi.org/10.1002/..

2

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pe..:

Biswas, Tithi ; Dowlati, Afshin ; Kunos, Charles A....
Clinical Cancer Research. 28 (2021) 4 - p. 646-652 , 2021

Link: https://doi.org/10.1158/..

3

An effective human uracil-DNA glycosylase inhibitor targets..:

Nguyen, My T. ; Moiani, Davide ; Ahmed, Zamal...
Progress in Biophysics and Molecular Biology. 163 (2021) - p. 143-159 , 2021

Link: https://doi.org/10.1016/..

4

Correction:

Ahmad, Faiz ; Alam, Intekhab ; Huff, Sarah E....
Proceedings of the National Academy of Sciences of the United States of America. 117 (2020) 48 - p. 30858 ff. , 2020

Link: https://www.jstor.org/st..

5

Phase I clinical trial of temozolomide and methoxyamine (TR..:

Eads, Jennifer R. ; Krishnamurthi, Smitha S. ; Saltzman, Joel...
Investigational New Drugs. 39 (2020) 1 - p. 142-151 , 2020

Link: https://doi.org/10.1007/..

6

Structure-guided design of anti-cancer ribonucleotide reduc..:

Misko, Tessianna A. ; Liu, Yi-Ting ; Harris, Michael E....
Journal of Enzyme Inhibition and Medicinal Chemistry. 34 (2019) 1 - p. 438-450 , 2019

Link: https://doi.org/10.1080/..

7

Structure-Guided Synthesis and Mechanistic Studies Reveal S..:

Huff, Sarah E. ; Mohammed, Faiz Ahmad ; Yang, Mu...
Journal of Medicinal Chemistry. 61 (2018) 3 - p. 666-680 , 2018

Link: https://doi.org/10.1021/..

8

MMR Deficiency Does Not Sensitize or Compromise the Functio..:

Patel, Rutulkumar ; Qing, Yulan ; Kennedy, Lucy...
Stem Cells Translational Medicine. 7 (2018) 7 - p. 513-520 , 2018

Link: https://doi.org/10.1002/..

9

Potent competitive inhibition of human ribonucleotide reduc..:

Ahmad, Md. Faiz ; Alam, Intekhab ; Huff, Sarah E....
Proceedings of the National Academy of Sciences of the United States of America. 114 (2017) 31 - p. 8241-8246 , 2017

Link: https://www.jstor.org/st..

10

Potent competitive inhibition of human ribonucleotide reduc..:

Ahmad, Md. Faiz ; Alam, Intekhab ; Huff, Sarah E....
Proceedings of the National Academy of Sciences. 114 (2017) 31 - p. 8241-8246 , 2017

Link: https://doi.org/10.1073/..

11

Phase I clinical trial of the base excision repair inhibito..:

Caimi, Paolo F. ; Cooper, Brenda W. ; William, Basem M....
Oncotarget. 8 (2017) 45 - p. 79864-79875 , 2017

Link: https://doi.org/10.18632..

12

MEK inhibition abrogates sunitinib resistance in a renal ce..:

Diaz-Montero, C Marcela ; Mao, Frances J ; Barnard, John...
British Journal of Cancer. 115 (2016) 8 - p. 920-928 , 2016

Link: https://doi.org/10.1038/..

13

Identification of Non-nucleoside Human Ribonucleotide Reduc..:

Ahmad, Md. Faiz ; Huff, Sarah E. ; Pink, John...
Journal of Medicinal Chemistry. 58 (2015) 24 - p. 9498-9509 , 2015

Link: https://doi.org/10.1021/..

14

A synthetic peptide targeting the BH4 domain of Bcl-2 induc..:

Lavik, Andrew R. ; Zhong, Fei ; Chang, Ming-Jin...
Oncotarget. 6 (2015) 29 - p. 27388-27402 , 2015

Link: https://doi.org/10.18632..

15

Pharmacogenomic Approach to Identify Drug Sensitivity in Sm..:

Wildey, Gary ; Chen, Yanwen ; Lent, Ian...
PLoS ONE. 9 (2014) 9 - p. e106784 , 2014

Link: https://doi.org/10.1371/..